PRO-DEX, INC. Cash and Restricted Cash
PRO-DEX, INC. (PDEX) had Cash and Restricted Cash of $8.19 million as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-03
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.19M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.99M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.95M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $514.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $8.19M 10-K · filed 2026-09-03 |
| 2026-03-31 | $9.99M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $7.95M 10-Q · filed 2026-01-29 |
| 2025-09-30 | $514.00K 10-Q · filed 2025-10-30 |
| 2025-06-30 | $419.00K 10-K · filed 2026-09-03 |
| 2025-03-31 | $4.47M 10-Q · filed 2026-04-30 |
| 2024-12-31 | $66.00K 10-Q · filed 2026-01-29 |
| 2024-09-30 | $3.08M 10-Q · filed 2025-10-30 |
| 2024-06-30 | $2.63M 10-K · filed 2026-09-03 |
| 2024-03-31 | $3.22M 10-Q · filed 2025-05-01 |
| 2023-12-31 | $1.29M 10-Q · filed 2025-01-30 |
| 2023-09-30 | $1.90M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $2.94M 10-K · filed 2025-09-04 |
| 2023-03-31 | $2.09M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $382.00K 10-Q · filed 2024-02-08 |
| 2022-09-30 | $2.80M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $849.00K 10-K · filed 2024-09-05 |
| 2022-03-31 | $4.76M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $5.25M 10-Q · filed 2023-02-02 |
| 2021-09-30 | $5.18M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $3.72M 10-K · filed 2023-10-13 |
| 2021-03-31 | $3.87M 10-Q · filed 2022-05-05 |
| 2020-06-30 | $6.42M 10-K · filed 2023-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |